Cannabis-Based Product Proven To Be As Effective As Melatonin For Sleep In Large-Scale Study

In a pioneering study recently published in the journal Pharmaceuticals, researchers have validated the effectiveness and safety of FloraWorks’ TruCBN in improving sleep quality. This study, conducted by Radicle Science, represents a significant milestone in cannabinoid research, marking the first time a cannabinoid has been clinically proven to enhance sleep quality in a large-scale, randomized, double-blind, placebo-controlled trial involving more than 1,000 participants.

A Significant Step In Cannabinoid Sleep Research

The study assessed the impact of three different doses of TruCBN (25 mg, 50 mg, and 100 mg) on sleep quality, comparing the results to those of a placebo and a standard 4 mg dose of melatonin. The 1,000 participants were diverse in gender, race and age provided a robust dataset for analysis.

Key Findings:

Participants taking 50 mg of TruCBN experienced significantly improved sleep quality compared to those on the placebo.
No …

Full story available on Benzinga.com